Role of hydrogen sulfide production in inhibitory action of L-cysteine on isolated porcine irides

Current Eye Research

Volumn 35, Issue 5, 2010, Pages 402-407

  Ohia, Sunny E ^a   Opere, Catherine A ^b   Monjok, Emmanuel M ^c   Kouamou, Ghislaine ^c   Leday, Angela M ^d   Njie Mbye, Ya Fatou ^a  

^a TEXAS SOUTHERN UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

^d SHIRE   (United States)

Author keywords

Hydrogen sulfide; K+ (ATP); L cysteine; Porcine irides; Prostanoids

Indexed keywords

AMINOOXYACETIC ACID; CARBACHOL; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; FLURBIPROFEN; GLIBENCLAMIDE; HYDROGEN SULFIDE; MUSCARINIC RECEPTOR; POTASSIUM CHANNEL BLOCKING AGENT; PROPARGYLGLYCINE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; SODIUM HYDROSULFIDE; SODIUM SULFIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; IC 50; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; SPHINCTER PUPILLAE MUSCLE; SWINE;

ANIMALS; CARBACHOL; CHOLINERGIC AGONISTS; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; HYDROGEN SULFIDE; IRIS; ISOMETRIC CONTRACTION; KATP CHANNELS; MUSCLE RELAXATION; MUSCLE, SMOOTH; RECEPTORS, MUSCARINIC; SWINE;

EID: 77952137968     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903576716     Document Type: Article

References (39)

1. Guidotti TL. Hydrogen sulphide. Occup Med (Lond). 1996;46:367-371.
2. Florin TH. Hydrogen sulphide and total acid-volatile sulphide in faeces, determined with a direct spectrophotometric method. Clin Chim Acta. 1991;196:127-134.
3. Kraft AA, Brant AW, Ayres JC. Detection of hydrogen sulphide in packaged meals and in broken-out shell eggs. Food Technology. 1956;10: 443-444.
4. Goffredi SK, Childress JJ, Desaulniers NT, et al. Sulfide acquisition by the vent worm Riftia pachyptila appears to be via uptake of HS-, rather than H2S. J Exp Biol. 1997;200:2609-2616.
5. Pitcher MC, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis. Gut. 2000;46:64-72.
6. Lowicka E, Beltowski J. Hydrogen sulfide (H2S)-The third gas of interest for pharmacologists. Pharmacol Rep. 2007;59:4-24.
7. Qu K, Lee SW, Bian JS, et al. Hydrogen sulfide: Neurochemistry and neurobiology. Neurochem Int. 2008;52:155-165.
8. Szabo C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov. 2007;6:917-935.
9. Bukovska G, Kery V, Kraus JP. Expression of human cystathionine beta-synthase in Escherichia coli: Purification and characterization. Protein Expr Purif. 1994;5:442-448.
10. Erickson PF, Maxwell IH, Su LJ, et al. Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes. Biochem J. 1990;269:335-340.
11. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat. Biochem J. 1982;206:267-277.
12. Swaroop M, Bradley K, Ohura T, et al. Rat cystathionine beta-synthase. Gene organization and alternative splicing. J Biol Chem. 1992;267:11455-11461.
13. Hosoki R, Matsuki N, Kimura H. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. Biochem Biophys Res Commun. 1997;237:527-531.
14. Levonen AL, Lapatto R, Saksela M, et al. Human cystathionine gamma-lyase: Developmental and in vitro expression of two isoforms. Biochem J. 2000;347:291-295.
15. Lu Y, O'Dowd BF, Orrego H, et al. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase. Biochem Biophys Res Commun. 1992;189:749-758.
16. Meier M, Janosik M, Kery V, et al. Structure of human cystathionine beta-synthase: A unique pyridoxal 5?-phosphatedependent heme protein. EMBO J. 2001;20:3910-3916.
17. Persa C, Osmotherly K, Chao-Wei CK, et al. The distribution of cystathionine beta-synthase (CBS) in the eye: Implication of the presence of a trans-sulfuration pathway for oxidative stress defense. Exp Eye Res. 2006;83:817-823.
18. Pong WW, Stouracova R, Frank N, et al. Comparative localization of cystathionine beta-synthase and cystathionine gamma-lyase in retina: Differences between amphibians and mammals. J Comp Neurol. 2007;505:158-165.
19. Yap S, Naughten ER, Wilcken B, et al. Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: Effects of homocysteine-lowering therapy. Semin Thromb Hemost. 2000;26:335-340.
20. Kimura H, Nagai Y, Umemura K, et al. Physiological roles of hydrogen sulfide: Synaptic modulation, neuroprotection, and smooth muscle relaxation. Antioxid Redox Signal. 2005;7:795-803.
21. Zhao W, Zhang J, Lu Y, et al. The vasorelaxant effect of H(2) S as a novel endogenous gaseous K(ATP) channel opener. EMBO J. 2001;20:6008-6016.
22. Zhao W, Wang R. H(2)S-induced vasorelaxation and underlying cellular and molecular mechanisms. Am J Physiol Heart Circ Physiol. 2002;283:H474-H480.
23. Hayden LJ, Franklin KJ, Roth SH, et al. Inhibition of oxytocin- induced but not angiotensin-induced rat uterine contractions following exposure to sodium sulfide. Life Sci. 1989;45:2557-2560.
24. Sidhu R, Singh M, Samir G, et al. L-cysteine and sodium hydrosulphide inhibit spontaneous contractility in isolated pregnant rat uterine strips in vitro. Pharmacol Toxicol. 2001;88:198-203.
25. Cheng Y, Ndisang JF, Tang G, et al. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol. 2004;287:H2316-H2323.
26. Tang G, Wu L, Liang W, et al. Direct stimulation of K(ATP) channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005;68:1757-1764.
27. Reiffenstein RJ, Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxicol. 1992;32:109-134.
28. Beauchamp RO, Jr., Bus JS, Popp JA, et al. A critical review of the literature on hydrogen sulfide toxicity. Crit Rev Toxicol. 1984;13:25-97.
29. Monjok EM, Kulkarni KH, Kouamou G, et al. Inhibitory action of hydrogen sulfide on muscarinic receptor-induced contraction of isolated porcine irides. Exp Eye Res. 2008;87:612-616.
30. Ohia SE, Opere CA, Monjok EM, et al. Role of hydrogen sulfide in L-cysteine induced relaxations of isolated porcine irides. Invest. Ophthalmol. Vis. Sci. 2007; E-Abstract 3945.
31. Kulkarni KH, Monjok EM, Zeyssig R, et al. Effect of hydrogen sulfide on sympathetic neurotransmission and catecholamine levels in isolated porcine iris-ciliary body. Neurochem Res. 2009;34:400-406.
32. Bhatia M. Hydrogen sulfide as a vasodilator. IUBMB Life. 2005;57:603-606.
33. Kiss L, Deitch EA, Szabo C. Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition. Life Sci. 2008;83:589-594.
34. Wang YF, Mainali P, Tang CS, et al. Effects of nitric oxide and hydrogen sulfide on the relaxation of pulmonary arteries in rats. Chin Med J (Engl ). 2008;121:420-423.
35. Dawe GS, Han SP, Bian JS, et al. Hydrogen sulphide in the hypothalamus causes an ATP-sensitive K(+) channeldependent decrease in blood pressure in freely moving rats. Neuroscience. 2008;152:169-177.
36. Srilatha B, Adaikan PG, Li L, et al. Hydrogen sulphide: A novel endogenous gasotransmitter facilitates erectile function. J Sex Med. 2007;4:1304-1311.
37. Teague B, Asiedu S, Moore PK. The smooth muscle relaxant effect of hydrogen sulphide in vitro: Evidence for a physiological role to control intestinal contractility. Br J Pharmacol. 2002;137:139-145.
38. Webb GD, Lim LH, Oh VM, et al. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther. 2008;324:876-882.
39. Dombkowski RA, Doellman MM, Head SK, et al. Hydrogen sulfide mediates hypoxia-induced relaxation of trout urinary bladder smooth muscle. J Exp Biol. 2006;209: 3234-3240.